
Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer
Keywords: سیس پلاتین; TP53; Mutations; NSCLC; Chemotherapy; Cisplatin; Randomized trial;